Interestingly, intra-cerebroventricular administration of BMP7 was shown to ameliorate the HFD-associated metabolic complications, suggesting that BMP7 may be explored as an attractive obesity therapeutic for diet-induced obesity and leptin-resistant conditions [14].. This evidence concerns the gene BMP7 and obesity due to melanocortin 4 receptor deficiency.